One week to go – Support Neola Medical in the Pioneer Prize

maj 6, 2025

Neola Medical is proud to be one of eight finalists for Sweden’s new global innovation award – the Pioneer Prize, launched by the Swedish Institute in collaboration with Business Sweden. The prize recognizes small and medium-sized companies offering groundbreaking, scalable solutions that support the green and digital transition.

Public voting is open until May 12. Cast your vote for Neola Medical here: Vote for Neola Medical

The winner will be announced on Sweden’s National Day at World Expo 2025 in Osaka.

Learn more here: Neola Medical – Pioneer Prize Nominee

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops an innovative medical technology device for non-invasive, continuous lung monitoring and real-time alerts of potentially life-threatening lung complications in preterm born babies. By enabling instant detection, the technology aims to support earlier intervention, improve clinical decision-making, enhance long-term outcomes, and ultimately contribute to saving lives. The patented, cutting-edge technology was developed at Lund University in Sweden and is based on a spectroscopic method that measures changes in lung volume and oxygen gas concentration. Neola Medical builds on Sweden’s longstanding legacy of medical technology innovation and contributions to global health care. Neola Medical was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Image Attachments
No1 NeolaMedical Hanna Sjöström

Attachments
One week to go – Support Neola Medical in the Pioneer Prize